[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE198335T1 - Cc-1065-analoge mit zwei cpi-subeinheiten - Google Patents

Cc-1065-analoge mit zwei cpi-subeinheiten

Info

Publication number
ATE198335T1
ATE198335T1 AT89308920T AT89308920T ATE198335T1 AT E198335 T1 ATE198335 T1 AT E198335T1 AT 89308920 T AT89308920 T AT 89308920T AT 89308920 T AT89308920 T AT 89308920T AT E198335 T1 ATE198335 T1 AT E198335T1
Authority
AT
Austria
Prior art keywords
pct
formula
date mar
compounds
cpi
Prior art date
Application number
AT89308920T
Other languages
English (en)
Inventor
Robert C Kelly
Paul A Aristoff
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE198335T1 publication Critical patent/ATE198335T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Error Detection And Correction (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Amplifiers (AREA)
  • Solid State Image Pick-Up Elements (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Artificial Filaments (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Stereophonic System (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Television Receiver Circuits (AREA)
  • Television Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT89308920T 1988-09-12 1989-09-04 Cc-1065-analoge mit zwei cpi-subeinheiten ATE198335T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24335088A 1988-09-12 1988-09-12
PCT/US1989/003329 WO1990002746A1 (en) 1988-09-12 1989-08-07 Novel cc-1065 analogs having two cpi subunits

Publications (1)

Publication Number Publication Date
ATE198335T1 true ATE198335T1 (de) 2001-01-15

Family

ID=22918400

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89308920T ATE198335T1 (de) 1988-09-12 1989-09-04 Cc-1065-analoge mit zwei cpi-subeinheiten

Country Status (14)

Country Link
US (1) US5541339A (de)
JP (1) JP3380237B2 (de)
KR (1) KR0137959B1 (de)
AT (1) ATE198335T1 (de)
AU (1) AU632288B2 (de)
CA (1) CA1340215C (de)
DE (1) DE68929275T2 (de)
DK (1) DK175458B1 (de)
FI (1) FI103668B (de)
GR (1) GR3035589T3 (de)
LV (1) LV12806B (de)
NO (1) NO303498B1 (de)
TW (1) TW217383B (de)
WO (1) WO1990002746A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563475B1 (de) * 1992-03-25 2000-05-31 Immunogen Inc Konjugaten von Zell-bindender Mittel und Derivaten von CC-1065
US5502068A (en) * 1995-01-31 1996-03-26 Synphar Laboratories, Inc. Cyclopropylpyrroloindole-oligopeptide anticancer agents
JP4414142B2 (ja) 2001-05-11 2010-02-10 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ 特異的結合タンパク質およびその使用
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
BR0214019A (pt) 2001-11-09 2004-10-13 Boehringer Ingelheim Phamaceut Benzimidazóis úteis como inibidores de proteìna quinase
JP2005536533A (ja) * 2002-08-08 2005-12-02 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 置換ベンゾイミダゾール化合物
CA2501547A1 (en) * 2002-10-15 2004-04-29 Rigel Pharmaceuticals, Inc. Substituted indoles and their use as hcv inhibitors
EP1641759B1 (de) * 2003-07-07 2014-03-12 Merck Patent GmbH Malonamidderivate
US20050209284A1 (en) * 2004-02-12 2005-09-22 Boehringer Ingelheim Pharmaceuticals, Inc. Tec kinase inhibitors
JP2009504756A (ja) * 2005-08-17 2009-02-05 シェーリング コーポレイション 新規な高親和性のチオフェンベースおよびフランベースのキナーゼリガンド
MX2009007987A (es) 2007-01-25 2010-03-01 Dana Farber Cancer Inst Inc Uso de anticuerpos anti-egfr en el tratamiento de enfermedad mediada por egfr mutante.
CN101688229B (zh) 2007-03-15 2013-06-12 路德维格癌症研究所 包含egfr抗体和src抑制剂的组合物及其在制备用于治疗哺乳动物癌症的药物中的用途
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
MX2010001757A (es) 2007-08-14 2010-09-14 Ludwig Inst Cancer Res Anticuerpo monoclonal 175 que activa el receptor egf y derivados y usos del mismo.
LT2344478T (lt) 2008-11-03 2018-01-10 Syntarga B.V. Cc-1065 analogai ir jų konjugatai
KR101901555B1 (ko) 2010-04-21 2018-09-21 신타가 비.브이. Ｃｃ―１０６５ 유사체와 2작용성 링커의 신규한 콘쥬게이트
EP3388060A1 (de) 2012-10-22 2018-10-17 Arnold Glazier Verfahren zur effektiven behandlung von metastasierendem tumor
DE102013012622A1 (de) * 2013-07-30 2015-02-05 Clariant lnternational Ltd Neue sterisch gehinderte cyclische Amine
MY177390A (en) 2014-01-10 2020-09-14 Byondis Bv Method for purifying cys-linked antibody-drug conjugates
CN106459055B (zh) * 2014-01-27 2019-11-01 辉瑞大药厂 双功能细胞毒类药剂
WO2016001485A1 (en) 2014-06-30 2016-01-07 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
DE102015000124A1 (de) * 2015-01-07 2016-07-07 Clariant International Ltd. Verfahren zur Stabilisierung von Polyamiden
WO2016151432A1 (en) * 2015-03-20 2016-09-29 Pfizer Inc. Bifunctional cytotoxic agents containing the cti pharmacophore

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169888A (en) * 1977-10-17 1979-10-02 The Upjohn Company Composition of matter and process
US4301248A (en) * 1979-12-21 1981-11-17 Bristol-Myers Company Fermentation process for making rachelmycin
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
US4912227A (en) * 1984-02-21 1990-03-27 The Upjohn Company 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
CA1238907A (en) * 1984-02-21 1988-07-05 Robert C. Kelly 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds
GB8528848D0 (en) * 1985-11-22 1985-12-24 Davy Mckee Poole Rolling mills
WO1988004659A2 (en) * 1986-12-19 1988-06-30 The Upjohn Company Novel cc-1065 analogs

Also Published As

Publication number Publication date
KR0137959B1 (ko) 1998-05-15
JPH04500664A (ja) 1992-02-06
LV12806B (lv) 2002-05-20
FI911193A0 (fi) 1991-03-11
LV12806A (en) 2002-03-20
AU632288B2 (en) 1992-12-24
FI103668B1 (fi) 1999-08-13
DE68929275T2 (de) 2001-05-23
TW217383B (de) 1993-12-11
DK41791A (da) 1991-03-08
DK175458B1 (da) 2004-11-01
KR900701801A (ko) 1990-12-04
NO910958D0 (no) 1991-03-11
DK41791D0 (da) 1991-03-08
JP3380237B2 (ja) 2003-02-24
NO303498B1 (no) 1998-07-20
GR3035589T3 (en) 2001-06-29
WO1990002746A1 (en) 1990-03-22
FI103668B (fi) 1999-08-13
US5541339A (en) 1996-07-30
AU4192289A (en) 1990-04-02
CA1340215C (en) 1998-12-15
DE68929275D1 (de) 2001-02-01
NO910958L (no) 1991-05-10

Similar Documents

Publication Publication Date Title
ATE198335T1 (de) Cc-1065-analoge mit zwei cpi-subeinheiten
PT653439E (pt) Oligonucleotidos e sua aplicacao
DK0556310T3 (da) Quinazolinderivater til forhøjelse af antitumoraktivitet
DK0631575T3 (da) Substituerede pyrimidiner samt deres anvendelse som fungicider
DE69633679D1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
TR200002616T2 (tr) Simetrik ve simetrik olmayan sübstitüe edilmiş difenil üreler kullanılarak raf kinazın inhibe edilmesi
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
BR1100989A (pt) Composto e composição de matéria
ATE112279T1 (de) Cc-1065 analoge.
DE3774286D1 (de) (2,2-bis(aminomethyl)-1,3-propandiol-n,n')platin-komplexe.
DK0411733T3 (da) 11-beta-aryl-gona-4,9-dien-3-oner
TR23462A (tr) Karbamat ve tiyokarbamat olabilen aromatik bilesiklerle hasaratin bueyuemesini ayarlayin bilesikleri ihtiva eden zararlilari kontrol altina almaya mahsus bilesimler
ITMI920955A1 (it) Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili
DE3761138D1 (de) Nitratderivate und ihre verwendung als gefaesserweiterer.
ATE51001T1 (de) Koordinationsverbindungen von platin.
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
DK24687A (da) 3-alkoxyflavonderivater samt antiviralt virksomme terapeutiske midler indeholdende disse
ATE93846T1 (de) S-substituierte beta-thioacrylamide und deren verwendung als mikrobizide.
NO960271D0 (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
DE3768322D1 (de) Substituierte alkynische thiocyanate, sie enthaltende biozide zusammensetzungen und deren verwendung.
ATE174911T1 (de) 1-dimethylcarbamoyl-1h-1,2,4-triazole- substituiert in stellungen 3 und 5
DE3571975D1 (de) Azidobenzazepines
DE59810106D1 (de) Substituierte 2,4-diamino-1,3,5-triazine
DE3782831D1 (de) (gem-heterocyclodimethanamin-n,n')platin komplexe.
DE69909010D1 (de) Verwendung von procyanidolischen Oligomeren oder Anthocyanosiden als Anti-Urease Wirkstoffe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee